Brief: Bergenbio Gets Approval For COVID-19 South Africa Trial
25/09/2020 08:18
Sept 25 (Reuters) - Bergenbio ASA BGBIO.OL :
* SAID ON THURSDAY RECEIVED APPROVAL FROM NORWEGIAN REGIONAL
ETHICS COMMITTEE FOR COVID-19 SOUTH AFRICA TRIAL
Source text for Eikon: ID:nWkr8Gd030
Further company coverage: BGBIO.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Oncoinvent ASA
See all newsBrief: Oncoinvent To Raise Up To NOK 140 Million In Private Placement
Brief: Oncoinvent H1 Operating Loss NOK 69 Mln
Brief: Oncoinvent Secures New Patent Expanding Protection For Radspherin
Brief: Oncoinvent's Shares To Be Consolidated In Ratio Of 100:1
Brief: Oncoinvent To Increase Share Capital In Connection With Settlement Of Underwriting Fee